Apoptosis analysis in A549 (lung cancer) and CFPAC-1 (pancreatic cancer) cells was performed to determine whether GRB7 mediates MEKi resistance in other RAS-driven cancer types. The gene discussed is GRB7; the disease is pancreatic neoplasm.